home / stock / dtcff / dtcff news

DTCFF News and Press, Defence Therapeutics Inc Cl A From 02/02/23

Stock Information
Company Name: Defence Therapeutics Inc Cl A
Stock Symbol: DTCFF
Market: OTC
Website: defencetherapeutics.com
Menu
DTCFF DTCFF Quote DTCFF Short DTCFF News DTCFF Articles DTCFF Message Board
Get DTCFF Alerts

News, Short Squeeze, Breakout and More Instantly...
DTCFF - Defence Therapeutics and CQDM Fund the Development of a New Cancer Vaccine Platform

Montreal, Quebec--(Newsfile Corp. - February 2, 2023) - In celebration of World Cancer Day, Defence Therapeutics and CQDM are proud to announce the launch of a collaborative research project between Université de Montréal (UdeM), the Lady Davis Institute of the Jewish General Hospital a...
DTCFF - Defence's Lung Cancer GLP tox Study on Its Intranasal AccuTOX(TM) Formulation Advances

Vancouver, British Columbia--(Newsfile Corp. - January 31, 2023) - Defence Therapeutics Inc. (CSE: DTC) (FSE: DTC) (OTC Pink: DTCFF) (" Defence " or the " Company "), a Canadian biopharmaceutical company specialized in the development of immune-oncology vaccines and drug delivery technologies is ...

DTCFF - Defence's Melanoma Targeted Vaccine A1-Reprogrammed MSC (ARM) Cell Potency Validated

Vancouver, British Columbia--(Newsfile Corp. - January 24, 2023) - Defence Therapeutics Inc. (CSE: DTC) (FSE: DTC) (OTC Pink: DTCFF) (" Defence " or the " Company "), a Canadian biopharmaceutical company specialized in the development of immune-oncology vaccines and drug delivery technologies, is...

DTCFF - RETRANSMISSION: Defence to Present at the 9th Annual Immuno-Oncology 360º Summit in New-York February 7-10, 2023

Vancouver, British Columbia--(Newsfile Corp. - January 23, 2023) - Defence Therapeutics Inc. (CSE: DTC) (FSE: DTC) (OTC Pink: DTCFF) (" Defence " or the " Company "), a Canadian biopharmaceutical company specialized in the development of immune-oncology vaccines and drug delivery technologies, is...
DTCFF - Defence To Present at The 9th Annual Immuno-Oncology 360 Summit in New-York February 7-10, 2023

Vancouver, British Columbia--(Newsfile Corp. - January 20, 2023) - Defence Therapeutics Inc. (CSE: DTC) (FSE: DTC) (OTC Pink: DTCFF) (" Defence " or the " Company "), a Canadian biopharmaceutical company specialized in the development of immune-oncology vaccines and drug delivery technologies, is...

DTCFF - Defence Therapeutics to get US patent linked to vaccine technology

Defence Therapeutics ( OTCPK:DTCFF ) said the U.S. Patent and Trademark Office (USPTO) issued a notice of allowance for its vaccine technology. The US patent application number 17/738,548 covers the use of components of Defence's proprietary Accum technology as a 'drop-in' enhanc...

DTCFF - Defence Accum(TM) Accepted Us Patent to Bolster Its Vaccine Platform Technology IP

Vancouver, British Columbia--(Newsfile Corp. - January 16, 2023) - Defence Therapeutics Inc. (CSE: DTC) (FSE: DTC) (OTC Pink: DTCFF) (" Defence " or the " Company "), a Canadian biopharmaceuticals company primarily focussed on the development of novel immune-oncology vaccines and drug delivery te...
DTCFF - mRNA with Defence's Accum(TM) Program Has Been Initiated

Vancouver, British Columbia--(Newsfile Corp. - January 10, 2023) - Defence Therapeutics Inc. (CSE: DTC) (FSE: DTC) (OTC Pink: DTCFF) (" Defence " or the " Company "), a Canadian biopharmaceutical company specialized in the development of immune-oncology vaccines and drug delivery technologies, is...

DTCFF - Breakthrough Results: Defence's Novel AccuTOX(TM) Intranasal Reduced 50% of Cancer Nodules on Animals with Lung Tumors

Vancouver, British Columbia--(Newsfile Corp. - December 20, 2022) - Defence Therapeutics Inc. (CSE: DTC) (FSE: DTC) (OTC Pink: DTCFF) (" Defence " or the " Company "), a Canadian biopharmaceutical company specialized in the development of immune-oncology vaccines and drug delivery technologi...

DTCFF - Defence's mRNA with Accum(TM) for Cancer Vaccines Update

Vancouver, British Columbia--(Newsfile Corp. - December 15, 2022) - Defence Therapeutics Inc. (CSE: DTC) (FSE: DTC) (OTC Pink: DTCFF) (" Defence " or the " Company "), a Canadian biopharmaceutical company specialized in the development of immune-oncology vaccines and drug delivery technologies, i...
Previous 10 Next 10